Folotyn is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Allos Therapeutics. The primary component is Pralatrexate.
Product ID | 48818-001_1ed02005-69ec-499f-bf23-3100b06651f8 |
NDC | 48818-001 |
Product Type | Human Prescription Drug |
Proprietary Name | Folotyn |
Generic Name | Pralatrexate |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2009-09-24 |
Marketing Category | NDA / NDA |
Application Number | NDA022468 |
Labeler Name | Allos Therapeutics |
Substance Name | PRALATREXATE |
Active Ingredient Strength | 20 mg/mL |
Pharm Classes | Folate Analog Metabolic Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2009-09-24 |
Marketing End Date | 2023-06-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022468 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2009-09-24 |
Marketing Category | NDA |
Application Number | NDA022468 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2009-09-24 |
Ingredient | Strength |
---|---|
PRALATREXATE | 20 mg/mL |
SPL SET ID: | 5e4cf15b-bf7b-4b83-863e-e9ef27741a51 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
48818-001 | Folotyn | pralatrexate |
72893-003 | Folotyn | pralatrexate |
72893-005 | Folotyn | pralatrexate |
65219-550 | Pralatrexate | Pralatrexate |
65219-552 | Pralatrexate | Pralatrexate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FOLOTYN 78881722 3743409 Live/Registered |
Allos Therapeutics, Inc. 2006-05-11 |
FOLOTYN 77939090 3887969 Dead/Cancelled |
Allos Therapeutics, Inc. 2010-02-18 |